News
Preliminary, Unaudited Second Quarter 2025 Financial Results and Business Updates Announced on August 8, 2025, that the U.S.
Genio is a different approach to hypoglossal nerve stimulation (HGNS) for the treatment of OSA. Genio’s unique design ...
CLEARWATER, Fla., June 24, 2025 /PRNewswire/ -- Genio, a provider of learning tools that significantly improve student success, today released the Genio New Majority Learner Report 2025.
“AI can be used as a gym – a place for training, challenge, and growth – or as a diet pill, a way to bypass effort in the ...
1d
Zacks Investment Research on MSNNyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea
Nyxoah NYXH recently received FDA approval for its Genio system, an innovative therapy for moderate to severe Obstructive Sleep Apnea (OSA). Featuring a leadless, battery-free design powered by an ...
Genio also unveiled The Confident Notetaker's Masterclass, an hour-long, tool-agnostic interactive course created by learning experts that teaches participants techniques and strategies to enhance ...
The FDA has approved the Genio® system for treating patients with moderate to severe obstructive sleep apnea (OSA) with an ...
The Samsung Genio Slide combines a 2.8-inch touchscreen display and a slide-out QWERTY keyboard, and sports the colourful swappable back panels and youth-targeted features – with an emphasis on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results